Literature DB >> 17112797

Colon cancer prevention in Italy: cost-effectiveness analysis with CT colonography and endoscopy.

C Hassan1, A Zullo, A Laghi, I Reitano, F Taggi, P Cerro, F Iafrate, M Giustini, S Winn, S Morini.   

Abstract

BACKGROUND: Colorectal cancer (CRC) is a major cause of mortality in Italy. Although prevention of CRC is possible, its cost-effectiveness when applied to the Italian population is unknown. Recently, computerized tomographic colonography (CTC) has been proposed for CRC screening. AIM: To compare the efficacy and cost-effectiveness of CTC screening in a simulated Italian population with those of colonoscopy and flexible sigmoidoscopy (FS).
METHODS: The cost-effectiveness of different screening strategies was compared using a Markov process computer model, in which in a hypothetical population of 100,000 50 year-olds were investigated by CTC, colonoscopy or FS every decade. Outcomes were projected to the Italian national level.
RESULTS: CRC incidence reduction was calculated at 40.9%, 38.2%, and 31.8% with colonoscopy, CTC and FS, respectively. As compared to no screening, all screening programs were shown to be cost-saving, allowing a saving of 11 Euro, 17 Euro, and 48 Euro per person with colonoscopy, FS and CTC, respectively. FS appeared to be less cost-effective than CTC, whilst colonoscopy appeared to be an expensive option as compared to CTC. Undiscounted national expenditure was calculated to be 1,042,489,512 Euro, 1,093,268,285 Euro, and 1,198,783,428 Euro for FS, CTC and colonoscopy, respectively, as compared to 695,818,078 Euro without screening.
CONCLUSION: CRC screening is cost-saving in Italy, irrespective of the technique applied. CTC appeared to be more cost-effective than FS, and it may also become a valid alternative to colonoscopy.

Entities:  

Mesh:

Year:  2006        PMID: 17112797     DOI: 10.1016/j.dld.2006.09.016

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN: 1590-8658            Impact factor:   4.088


  20 in total

1.  The dynamics of colorectal cancer management in 17 countries.

Authors:  Panos Kanavos; Willemien Schurer
Journal:  Eur J Health Econ       Date:  2010-01

Review 2.  CT colonography and cost-effectiveness.

Authors:  Ifigeneia Mavranezouli; James E East; Stuart A Taylor
Journal:  Eur Radiol       Date:  2008-06-27       Impact factor: 5.315

3.  Evaluation of screening strategies for pre-malignant lesions using a biomathematical approach.

Authors:  Jihyoun Jeon; Rafael Meza; Suresh H Moolgavkar; E Georg Luebeck
Journal:  Math Biosci       Date:  2008-02-26       Impact factor: 2.144

4.  Screening methods for early detection of colorectal cancers and polyps: summary of evidence-based analyses.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2009-09-01

5.  Variation in diagnostic performance among radiologists at screening CT colonography.

Authors:  B Dustin Pooler; David H Kim; Cesare Hassan; Antonio Rinaldi; Elizabeth S Burnside; Perry J Pickhardt
Journal:  Radiology       Date:  2013-02-28       Impact factor: 11.105

6.  Colorectal cancer screening: the role of CT colonography.

Authors:  Andrea Laghi; Franco Iafrate; Marco Rengo; Cesare Hassan
Journal:  World J Gastroenterol       Date:  2010-08-28       Impact factor: 5.742

7.  Cost-effectiveness of colorectal cancer screening - an overview.

Authors:  Iris Lansdorp-Vogelaar; Amy B Knudsen; Hermann Brenner
Journal:  Best Pract Res Clin Gastroenterol       Date:  2010-08       Impact factor: 3.043

8.  Computed tomography colonography (virtual colonoscopy): climax of a new era of validation and transition into community practice.

Authors:  Jacob Thomas; Jeffrey Carenza; Elizabeth McFarland
Journal:  Clin Colon Rectal Surg       Date:  2008-08

9.  Effect of rising chemotherapy costs on the cost savings of colorectal cancer screening.

Authors:  Iris Lansdorp-Vogelaar; Marjolein van Ballegooijen; Ann G Zauber; J Dik F Habbema; Ernst J Kuipers
Journal:  J Natl Cancer Inst       Date:  2009-09-24       Impact factor: 13.506

Review 10.  CT colonography for population screening of colorectal cancer: hints from European trials.

Authors:  Lapo Sali; Daniele Regge
Journal:  Br J Radiol       Date:  2016-09-14       Impact factor: 3.039

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.